| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.03 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.04 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.04 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |